Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

Biochemical and Biophysical Research Communications - Tập 118 Số 1 - Trang 27-32 - 1984
Hing-Yat Peter Lam1,2
1Department of Pharmacology University of Manitoba, Winnipeg, Manitoba R3E 0V9, Canada
2Manitoba Institute of Cell Biology Department of Medicine University of Manitoba, Winnipeg, Manitoba R3E 0V9, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Wang, 1979, Current Topics in Cellular Regulation, 15, 47, 10.1016/B978-0-12-152815-7.50006-5

Cheung, 1980, Science, 207, 19, 10.1126/science.6243188

Weiss, 1982, Biochem. Pharm, 31, 2217, 10.1016/0006-2952(82)90104-6

Heuson, 1976, Cancer Treat. Report, 60, 1463

Pearson, 1982, Cancer Res, 42, 3424s

Jordan, 1976, Cancer Treat. Reports, 60, 1409

Horwitz, 1978, Can. J. Biol. Chem, 253, 8185, 10.1016/S0021-9258(17)34379-X

Charbonneau, 1979, Biochem. Biophys. Res. Comm, 90, 1039, 10.1016/0006-291X(79)91931-4

Sharma, 1983, Methods in Enzymology, 102

Sharma, 1979, Advances in Cyclic Nucleotide Research, 10, 187

Fiske, 1925, J. Biol. Chem, 66, 375, 10.1016/S0021-9258(18)84756-1

Sutherland, 1980, Nature, 288, 273, 10.1038/288273a0

Sudo, 1983, Endocrinology, 112, 425, 10.1210/endo-112-2-425

Winneker, 1983, Endocrinology, 112, 1823, 10.1210/endo-112-5-1823

Miller, 1983, Cancer Res, 43, 3094

Ito, 1983, Cancer letters, 19, 215, 10.1016/0304-3835(83)90157-X

Moon, 1983, 24, 263